Lepisosteus oculatus isolate Spotted Gar 1 linkage group LG27, LepOcu1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Holostei; Semionotiformes; Lepisosteidae; Lepisosteus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM001430.1.\nAssembly name: LepOcu1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Broad Institute on\n2012/01/13. The original whole-genome shotgun project has the\naccession AHAT00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Broad Institute\nAssembly Method :: AllPaths v. R38293\nAssembly Name :: LepOcu1\nGenome Coverage :: 677.5x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Lepisosteus oculatus Annotation\n Release 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 6.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
USA: Bayou Chevreuil, St. James Parish, Louisiana
Derived by automated computational analysis using gene prediction method: Gnomon.
interferon regulatory factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
interferon regulatory factor 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
interferon regulatory factor 7, transcript variant X2
interferon regulatory factor 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
interferon regulatory factor 7 isoform X1
interferon regulatory factor 7 isoform X3
interferon regulatory factor 7 isoform X4
interferon regulatory factor 7 isoform X2
malignant fibrous histiocytoma-amplified sequence 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
PHD and ring finger domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PHD and ring finger domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PHD and ring finger domains 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
PHD and ring finger domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PHD and RING finger domain-containing protein 1 isoform X2
PHD and RING finger domain-containing protein 1 isoform X3
PHD and RING finger domain-containing protein 1 isoform X4
PHD and RING finger domain-containing protein 1 isoform X1
uncharacterized LOC107075798, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC107075798, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ras association domain-containing protein 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine rich repeat containing 56, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat containing 56, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine rich repeat containing 56, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat containing 56, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine rich repeat containing 56, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine rich repeat containing 56, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine rich repeat containing 56, transcript variant X7
leucine-rich repeat-containing protein 56 isoform X2
leucine-rich repeat-containing protein 56 isoform X1
leucine-rich repeat-containing protein 56 isoform X3
Harvey rat sarcoma viral oncogene homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 117 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Harvey rat sarcoma viral oncogene homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 117 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Harvey rat sarcoma viral oncogene homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 117 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Harvey rat sarcoma viral oncogene homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tumor susceptibility 101, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tumor susceptibility gene 101 protein isoform X1
tumor susceptibility 101, transcript variant X2
tumor susceptibility gene 101 protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 133 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
BR serine/threonine kinase 2, transcript variant X1
BR serine/threonine kinase 2, transcript variant X4
BR serine/threonine kinase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BR serine/threonine kinase 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BR serine/threonine kinase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BR serine/threonine kinase 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2 isoform X1
serine/threonine-protein kinase BRSK2 isoform X4
serine/threonine-protein kinase BRSK2 isoform X5
serine/threonine-protein kinase BRSK2 isoform X10
serine/threonine-protein kinase BRSK2 isoform X7
serine/threonine-protein kinase BRSK2 isoform X9
BR serine/threonine kinase 2, transcript variant X3
BR serine/threonine kinase 2, transcript variant X2
BR serine/threonine kinase 2, transcript variant X6
BR serine/threonine kinase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase BRSK2 isoform X6
serine/threonine-protein kinase BRSK2 isoform X3
serine/threonine-protein kinase BRSK2 isoform X2
serine/threonine-protein kinase BRSK2 isoform X8
uncharacterized LOC107075785, transcript variant X1
uncharacterized LOC107075785, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphatidylserine synthase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phosphatidylserine synthase 2, transcript variant X3
phosphatidylserine synthase 2 isoform X1
phosphatidylserine synthase 2 isoform X3
phosphatidylserine synthase 2, transcript variant X2
phosphatidylserine synthase 2 isoform X2
transient receptor potential cation channel, subfamily M, member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 5
cyclin-dependent kinase inhibitor 1B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
potassium channel, voltage gated KQT-like subfamily Q, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium channel, voltage gated KQT-like subfamily Q, member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium channel, voltage gated KQT-like subfamily Q, member 1, transcript variant X3
potassium voltage-gated channel subfamily KQT member 1 isoform X2
potassium voltage-gated channel subfamily KQT member 1 isoform X1
potassium voltage-gated channel subfamily KQT member 1 isoform X3
uncharacterized LOC107075800, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC107075800, transcript variant X1
uncharacterized oxidoreductase YjmC-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
interferon-induced transmembrane protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon-induced transmembrane protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
proline rich 5 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proline rich 5 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
proline rich 5 like, transcript variant X1
proline rich 5 like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
proline rich 5 like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
proline rich 5 like, transcript variant X3
TNF receptor associated factor 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TNF receptor associated factor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TNF receptor associated factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TNF receptor associated factor 6, transcript variant X5
TNF receptor associated factor 6, transcript variant X1
TNF receptor-associated factor 6 isoform X1
TNF receptor-associated factor 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tetratricopeptide repeat domain 17, transcript variant X1
tetratricopeptide repeat domain 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tetratricopeptide repeat domain 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tetratricopeptide repeat protein 17 isoform X1
tetratricopeptide repeat protein 17 isoform X2
uncharacterized LOC107075795, transcript variant X5
uncharacterized LOC107075795, transcript variant X9
uncharacterized LOC107075795, transcript variant X1
uncharacterized LOC107075795, transcript variant X6
uncharacterized LOC107075795, transcript variant X10
uncharacterized LOC107075795, transcript variant X3
uncharacterized LOC107075795, transcript variant X8
uncharacterized LOC107075795, transcript variant X2
uncharacterized LOC107075795, transcript variant X7
uncharacterized LOC107075795, transcript variant X4
hydroxysteroid (17-beta) dehydrogenase 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase alkB homolog 3
chromosome LG27 open reading frame, human C11orf96
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C11orf96 homolog
1-aminocyclopropane-1-carboxylate synthase-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
V(D)J recombination-activating protein 1
recombination activating gene 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
recombination activating gene 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
V(D)J recombination-activating protein 2
chromosome LG27 open reading frame, human C11orf74, transcript variant X3
chromosome LG27 open reading frame, human C11orf74, transcript variant X1
chromosome LG27 open reading frame, human C11orf74, transcript variant X2
uncharacterized protein C11orf74 homolog isoform X1
uncharacterized protein C11orf74 homolog isoform X2
uncharacterized protein C11orf74 homolog isoform X3
leucine rich repeat containing 4C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine rich repeat containing 4C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat containing 4C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine rich repeat containing 4C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine rich repeat containing 4C, transcript variant X8
leucine rich repeat containing 4C, transcript variant X5
leucine rich repeat containing 4C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine rich repeat containing 4C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 4C
ets homologous factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ets homologous factor, transcript variant X3
ets homologous factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
methylthioribulose-1-phosphate dehydratase
pyruvate dehydrogenase complex component X
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
pyruvate dehydrogenase protein X component, mitochondrial
solute carrier family 1 (glial high affinity glutamate transporter), member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 1 (glial high affinity glutamate transporter), member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 1 (glial high affinity glutamate transporter), member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 1 (glial high affinity glutamate transporter), member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 1 (glial high affinity glutamate transporter), member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 1 (glial high affinity glutamate transporter), member 2, transcript variant X6
peptidase domain containing associated with muscle regeneration 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
peptidase domain containing associated with muscle regeneration 1, transcript variant X1
inactive serine protease PAMR1 isoform X2
inactive serine protease PAMR1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
low density lipoprotein receptor class A domain containing 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
low-density lipoprotein receptor class A domain-containing protein 3
ras-related and estrogen-regulated growth inhibitor-like, transcript variant X2
ras-related and estrogen-regulated growth inhibitor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor-like isoform X1
ras-related and estrogen-regulated growth inhibitor-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
39S ribosomal protein L21, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
achaete-scute family bHLH transcription factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
MOB kinase activator 2, transcript variant X5
MOB kinase activator 2, transcript variant X4
MOB kinase activator 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
MOB kinase activator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
MOB kinase activator 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
MOB kinase activator 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MOB kinase activator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
dual specificity phosphatase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dual specificity phosphatase 8, transcript variant X3
dual specificity phosphatase 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dual specificity phosphatase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC107075782, transcript variant X9
uncharacterized LOC107075782, transcript variant X8
uncharacterized LOC107075782, transcript variant X5
uncharacterized LOC107075782, transcript variant X7
uncharacterized LOC107075782, transcript variant X4
uncharacterized LOC107075782, transcript variant X3
uncharacterized LOC107075782, transcript variant X6
uncharacterized LOC107075782, transcript variant X1
uncharacterized LOC107075782, transcript variant X2
uncharacterized protein LOC107075782 isoform X1
uncharacterized protein LOC107075782 isoform X4
uncharacterized protein LOC107075782 isoform X5
uncharacterized protein LOC107075782 isoform X3
uncharacterized protein LOC107075782 isoform X2
uncharacterized protein LOC107075782 isoform X6
uncharacterized protein LOC107075782 isoform X7
uncharacterized protein LOC107075782 isoform X8
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X2
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X18
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X19
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X14
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X15
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X12
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X17
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X13
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X11
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X4
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X5
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X6
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X1
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X22
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X24
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X3
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X8
tyrosine-protein phosphatase non-receptor type 5 isoform X1
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X9
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X21
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X10
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X20
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant X23
tyrosine-protein phosphatase non-receptor type 5 isoform X2
protein tyrosine phosphatase, receptor type J, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type J, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type J, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase eta isoform X1
receptor-type tyrosine-protein phosphatase eta isoform X2
receptor-type tyrosine-protein phosphatase eta isoform X3
oxysterol binding protein like 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
oxysterol binding protein like 5, transcript variant X4
oxysterol binding protein like 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
oxysterol binding protein like 5, transcript variant X7
oxysterol binding protein like 5, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
oxysterol binding protein like 5, transcript variant X11
oxysterol binding protein like 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
oxysterol-binding protein-related protein 5 isoform X1
oxysterol-binding protein-related protein 5 isoform X2
oxysterol binding protein like 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
oxysterol binding protein like 5, transcript variant X6
oxysterol-binding protein-related protein 5 isoform X3
oxysterol-binding protein-related protein 5 isoform X4
oxysterol binding protein like 5, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
oxysterol binding protein like 5, transcript variant X12
oxysterol binding protein like 5, transcript variant X10
oxysterol-binding protein-related protein 5 isoform X5
solute carrier family 22 member 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
solute carrier family 22 member 18, transcript variant X2
pleckstrin homology-like domain, family A, member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
pleckstrin homology-like domain family A member 2
nucleosome assembly protein 1-like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nucleosome assembly protein 1-like 4, transcript variant X2
nucleosome assembly protein 1-like 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nucleosome assembly protein 1-like 4 isoform X1
nucleosome assembly protein 1-like 4 isoform X2
cysteinyl-tRNA synthetase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cysteinyl-tRNA synthetase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cysteine--tRNA ligase, cytoplasmic isoform X2
cysteine--tRNA ligase, cytoplasmic isoform X1
carnitine O-palmitoyltransferase 1, liver isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
SITS-binding protein-like, transcript variant X5
SITS-binding protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SITS-binding protein-like, transcript variant X3
SITS-binding protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SITS-binding protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
39S ribosomal protein L23, mitochondrial, transcript variant X2
39S ribosomal protein L23, mitochondrial isoform X2
39S ribosomal protein L23, mitochondrial, transcript variant X1
39S ribosomal protein L23, mitochondrial isoform X1
tyrosine hydroxylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tyrosine hydroxylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
USP6 N-terminal-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
USP6 N-terminal-like protein, transcript variant X3
USP6 N-terminal-like protein, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 variant 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 variant 3-like
SPT2 chromatin protein domain containing 1, transcript variant X4
SPT2 chromatin protein domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
SPT2 chromatin protein domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
SPT2 chromatin protein domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SPT2 chromatin protein domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysoplasmalogenase-like protein TMEM86A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
beta-1,4-N-acetyl-galactosaminyl transferase 4
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1
ankyrin repeat and BTB (POZ) domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ankyrin repeat and BTB/POZ domain-containing protein 2
potassium channel, inwardly rectifying subfamily J, member 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATP-sensitive inward rectifier potassium channel 11
ATP binding cassette subfamily C member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP binding cassette subfamily C member 8, transcript variant X1
ATP-binding cassette sub-family C member 8 isoform X2
ATP-binding cassette sub-family C member 8 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
myogenic factor 6-like, transcript variant X1
myogenic factor 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
troponin T, fast skeletal muscle isoforms-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
troponin T, fast skeletal muscle isoforms-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
troponin T, fast skeletal muscle isoforms-like isoform X2
troponin T, fast skeletal muscle isoforms-like isoform X1
proline-rich extensin-like protein EPR1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
proline-rich extensin-like protein EPR1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
non-muscle caldesmon-like, transcript variant X2
non-muscle caldesmon-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
troponin I type 2 (skeletal, fast), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
troponin I type 2 (skeletal, fast), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
synaptotagmin-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
synaptotagmin-1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
synaptotagmin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
synaptotagmin-1-like, transcript variant X3
synaptotagmin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytosolic 5'-nucleotidase 1A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cytosolic 5'-nucleotidase 1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cytosolic 5'-nucleotidase 1A-like, transcript variant X4
cytosolic 5'-nucleotidase 1A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DEAF1, transcription factor, transcript variant X4
DEAF1, transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
DEAF1, transcription factor, transcript variant X3
DEAF1, transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
deformed epidermal autoregulatory factor 1 homolog isoform X4
deformed epidermal autoregulatory factor 1 homolog isoform X2
deformed epidermal autoregulatory factor 1 homolog isoform X3
deformed epidermal autoregulatory factor 1 homolog isoform X1
Bet1 golgi vesicular membrane trafficking protein like
RIC8 guanine nucleotide exchange factor A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RIC8 guanine nucleotide exchange factor A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
NAD-dependent protein deacetylase sirtuin-3, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NAD-dependent protein deacetylase sirtuin-3, mitochondrial isoform X2
26S proteasome non-ATPase regulatory subunit 13
cytochrome c oxidase subunit 8B, mitochondrial
metallothionein-like 5, testis-specific (tesmin)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
galanin/GMAP prepropeptide, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
galanin/GMAP prepropeptide, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sodium/hydrogen exchanger 10-like, transcript variant X3
sodium/hydrogen exchanger 10-like, transcript variant X1
sodium/hydrogen exchanger 10-like, transcript variant X2
protein phosphatase 6 regulatory subunit 3, transcript variant X2
protein phosphatase 6 regulatory subunit 3, transcript variant X6
protein phosphatase 6 regulatory subunit 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein phosphatase 6 regulatory subunit 3, transcript variant X13
protein phosphatase 6 regulatory subunit 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein phosphatase 6 regulatory subunit 3, transcript variant X8
protein phosphatase 6 regulatory subunit 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 6 regulatory subunit 3, transcript variant X1
protein phosphatase 6 regulatory subunit 3, transcript variant X15
protein phosphatase 6 regulatory subunit 3, transcript variant X16
protein phosphatase 6 regulatory subunit 3, transcript variant X10
protein phosphatase 6 regulatory subunit 3, transcript variant X9
protein phosphatase 6 regulatory subunit 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein phosphatase 6 regulatory subunit 3, transcript variant X5
protein phosphatase 6 regulatory subunit 3, transcript variant X3
protein phosphatase 6 regulatory subunit 3, transcript variant X4
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X10
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X9
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X8
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X11
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X6
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X3
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X5
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X4
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X7
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X2
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 5
chromosome LG27 open reading frame, human C11orf24
uncharacterized protein C11orf24 homolog
lysine (K)-specific methyltransferase 5B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
lysine (K)-specific methyltransferase 5B, transcript variant X1
lysine (K)-specific methyltransferase 5B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysine (K)-specific methyltransferase 5B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
histone-lysine N-methyltransferase SUV420H1
choline kinase alpha, transcript variant X1
choline kinase alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tumor protein p53 inducible protein 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tumor protein p53 inducible protein 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor protein p53 inducible protein 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
LIM domain only 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
LIM domain only 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 33 ESTs, 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 15A-like
pleckstrin homology domain containing A7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology domain containing A7, transcript variant X2
pleckstrin homology domain containing A7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology domain containing A7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pleckstrin homology domain containing A7, transcript variant X6
pleckstrin homology domain containing A7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pleckstrin homology domain containing A7, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pleckstrin homology domain containing A7, transcript variant X17
pleckstrin homology domain containing A7, transcript variant X10
pleckstrin homology domain containing A7, transcript variant X13
pleckstrin homology domain-containing family A member 7 isoform X1
pleckstrin homology domain-containing family A member 7 isoform X2
pleckstrin homology domain-containing family A member 7 isoform X5
pleckstrin homology domain-containing family A member 7 isoform X7
pleckstrin homology domain-containing family A member 7 isoform X6
pleckstrin homology domain-containing family A member 7 isoform X10
pleckstrin homology domain-containing family A member 7 isoform X12
pleckstrin homology domain-containing family A member 7 isoform X13
pleckstrin homology domain-containing family A member 7 isoform X4
pleckstrin homology domain-containing family A member 7 isoform X16
pleckstrin homology domain containing A7, transcript variant X15
pleckstrin homology domain containing A7, transcript variant X3
pleckstrin homology domain-containing family A member 7 isoform X3
pleckstrin homology domain containing A7, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pleckstrin homology domain containing A7, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pleckstrin homology domain-containing family A member 7 isoform X8
pleckstrin homology domain containing A7, transcript variant X9
pleckstrin homology domain-containing family A member 7 isoform X9
pleckstrin homology domain containing A7, transcript variant X11
pleckstrin homology domain-containing family A member 7 isoform X11
pleckstrin homology domain-containing family A member 7 isoform X14
pleckstrin homology domain containing A7, transcript variant X16
pleckstrin homology domain-containing family A member 7 isoform X15
chromosome LG27 open reading frame, human C11orf58, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromosome LG27 open reading frame, human C11orf58, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ethanolamine kinase 1-like, transcript variant X3
ethanolamine kinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ethanolamine kinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ethanolamine kinase 1-like, transcript variant X4
inscuteable homolog (Drosophila), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inscuteable homolog (Drosophila), transcript variant X1
inscuteable homolog (Drosophila), transcript variant X3
calcitonin-related polypeptide beta, transcript variant X3
calcitonin-related polypeptide beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
calcitonin-related polypeptide beta, transcript variant X4
calcitonin-related polypeptide beta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
calcitonin gene-related peptide 2 isoform X6
calcitonin gene-related peptide 2 isoform X5
calcitonin gene-related peptide 2 isoform X4
calcitonin gene-related peptide 2 isoform X3
calcitonin-related polypeptide beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcitonin-related polypeptide beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
calcitonin gene-related peptide 2 isoform X2
calcitonin gene-related peptide 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
cGMP-inhibited 3',5'-cyclic phosphodiesterase B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
related RAS viral (r-ras) oncogene homolog 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tubby bipartite transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tubby bipartite transcription factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tubby bipartite transcription factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubby bipartite transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubby bipartite transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC107075816, transcript variant X3
uncharacterized LOC107075816, transcript variant X1
uncharacterized LOC107075816, transcript variant X2
uncharacterized LOC107075816, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
serine/threonine kinase 33, transcript variant X5
serine/threonine kinase 33, transcript variant X1
serine/threonine kinase 33, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine kinase 33, transcript variant X3
serine/threonine kinase 33, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase 33 isoform X2
serine/threonine-protein kinase 33 isoform X1
ras-related and estrogen-regulated growth inhibitor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tripartite motif containing 66, transcript variant X3
tripartite motif containing 66, transcript variant X2
tripartite motif containing 66, transcript variant X1
tripartite motif-containing protein 66 isoform X1
tripartite motif-containing protein 66 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
suppression of tumorigenicity 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
suppression of tumorigenicity 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
suppression of tumorigenicity 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
suppression of tumorigenicity 5 protein isoform X2
suppression of tumorigenicity 5 protein isoform X1
A-kinase interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
A-kinase-interacting protein 1 isoform X1
A-kinase interacting protein 1, transcript variant X7
A-kinase interacting protein 1, transcript variant X3
A-kinase interacting protein 1, transcript variant X2
A-kinase interacting protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
A-kinase-interacting protein 1 isoform X2
A-kinase interacting protein 1, transcript variant X5
A-kinase interacting protein 1, transcript variant X6
A-kinase-interacting protein 1 isoform X3
chromosome LG27 open reading frame, human C11orf16, transcript variant X1
uncharacterized protein C11orf16 homolog isoform X1
chromosome LG27 open reading frame, human C11orf16, transcript variant X2
uncharacterized protein C11orf16 homolog isoform X2
TMEM9 domain family member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TMEM9 domain family member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
TMEM9 domain family member B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
signal peptide, CUB domain, EGF-like 2, transcript variant X3
signal peptide, CUB domain, EGF-like 2, transcript variant X4
signal peptide, CUB domain, EGF-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
signal peptide, CUB domain, EGF-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
signal peptide, CUB and EGF-like domain-containing protein 2 isoform X3
signal peptide, CUB and EGF-like domain-containing protein 2 isoform X2
signal peptide, CUB and EGF-like domain-containing protein 2 isoform X1
protein FAM60A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
protein FAM60A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 41B, transcript variant X1
transmembrane protein 41B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger protein 143, transcript variant X4
zinc finger protein 143, transcript variant X1
zinc finger protein 143, transcript variant X3
zinc finger protein 143, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SWAP switching B-cell complex 70kDa subunit
SET binding factor 2, transcript variant X5
SET binding factor 2, transcript variant X2
SET binding factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SET binding factor 2, transcript variant X3
SET binding factor 2, transcript variant X4
myotubularin-related protein 13 isoform X4
myotubularin-related protein 13 isoform X2
myotubularin-related protein 13 isoform X1
myotubularin-related protein 13 isoform X3
adenosine monophosphate deaminase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
adenosine monophosphate deaminase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
adenosine monophosphate deaminase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adenosine monophosphate deaminase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
adenosine monophosphate deaminase 3, transcript variant X5
ring finger protein 141, transcript variant X3
ring finger protein 141, transcript variant X1
ring finger protein 141, transcript variant X2
lymphatic vessel endothelial hyaluronan receptor 1
lymphatic vessel endothelial hyaluronic acid receptor 1
murine retrovirus integration site 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
CTR9 homolog, Paf1/RNA polymerase II complex component
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RNA polymerase-associated protein CTR9 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4 gamma, 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma, 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma, 2, transcript variant X3
eukaryotic translation initiation factor 4 gamma 2 isoform X1
eukaryotic translation initiation factor 4 gamma 2 isoform X2
polypeptide N-acetylgalactosaminyltransferase 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 18, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 18 isoform X1
polypeptide N-acetylgalactosaminyltransferase 18 isoform X2
phosphatidylinositol glycan anchor biosynthesis class Y
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol N-acetylglucosaminyltransferase subunit Y
BTB (POZ) domain containing 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
BTB/POZ domain-containing protein 10 isoform X2
BTB (POZ) domain containing 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
BTB/POZ domain-containing protein 10 isoform X1
aryl hydrocarbon receptor nuclear translocator like, transcript variant X6
aryl hydrocarbon receptor nuclear translocator like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like, transcript variant X5
aryl hydrocarbon receptor nuclear translocator like, transcript variant X3
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X3
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X2
aryl hydrocarbon receptor nuclear translocator-like protein 1 isoform X1
TBC1 domain family member 10A-like, transcript variant X2
TBC1 domain family member 10A-like, transcript variant X1
TBC1 domain family member 10A-like, transcript variant X4
TBC1 domain family member 10A-like, transcript variant X3
TBC1 domain family member 10A-like isoform X1
TBC1 domain family member 10A-like isoform X3
TBC1 domain family member 10A-like isoform X2
uncharacterized LOC107075788, transcript variant X2
uncharacterized LOC107075788, transcript variant X1
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ras association domain-containing protein 10
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X5
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TEA domain family member 1 (SV40 transcriptional enhancer factor), transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transcriptional enhancer factor TEF-1 isoform X4
transcriptional enhancer factor TEF-1 isoform X5
transcriptional enhancer factor TEF-1 isoform X3
transcriptional enhancer factor TEF-1 isoform X1
transcriptional enhancer factor TEF-1 isoform X6
transcriptional enhancer factor TEF-1 isoform X2
transcriptional enhancer factor TEF-1 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X13
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X11
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X10
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X8
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X7
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X1
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X3
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X4
protein-methionine sulfoxide oxidase MICAL2-like isoform X10
protein-methionine sulfoxide oxidase MICAL2-like isoform X2
protein-methionine sulfoxide oxidase MICAL2-like isoform X9
protein-methionine sulfoxide oxidase mical2b-like isoform X8
protein-methionine sulfoxide oxidase MICAL2-like isoform X7
protein-methionine sulfoxide oxidase MICAL2-like isoform X6
protein-methionine sulfoxide oxidase MICAL2-like isoform X4
protein-methionine sulfoxide oxidase mical2b-like isoform X3
protein-methionine sulfoxide oxidase mical2b-like isoform X1
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like isoform X5
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X16
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X15
protein-methionine sulfoxide oxidase MICAL2-like isoform X12
protein-methionine sulfoxide oxidase MICAL2-like isoform X11
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X19
protein-methionine sulfoxide oxidase MICAL2-like isoform X13
protein-methionine sulfoxide oxidase MICAL2-like, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dickkopf WNT signaling pathway inhibitor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dickkopf WNT signaling pathway inhibitor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ubiquitin specific peptidase 47, transcript variant X2
ubiquitin specific peptidase 47, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ubiquitin specific peptidase 47, transcript variant X4
ubiquitin specific peptidase 47, transcript variant X6
ubiquitin specific peptidase 47, transcript variant X1
ubiquitin specific peptidase 47, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 47 isoform X4
ubiquitin carboxyl-terminal hydrolase 47 isoform X2
ubiquitin carboxyl-terminal hydrolase 47 isoform X3
ubiquitin carboxyl-terminal hydrolase 47 isoform X1
ubiquitin carboxyl-terminal hydrolase 47 isoform X6
ubiquitin carboxyl-terminal hydrolase 47 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
fatty acyl-CoA reductase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
fatty acyl-CoA reductase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X12
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X15
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X11
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X13
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X9
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X16
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X8
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X4
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X6
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X7
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X3
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X1
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X2
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X10
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X5
PTPRF interacting protein, binding protein 2 (liprin beta 2), transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC107075802, transcript variant X2
uncharacterized LOC107075802, transcript variant X3
uncharacterized LOC107075802, transcript variant X1
uncharacterized LOC107075802, transcript variant X4
uncharacterized protein LOC107075802 isoform X1
uncharacterized LOC107075802, transcript variant X5
uncharacterized protein LOC107075802 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromosome LG27 open reading frame, human C11orf91
uncharacterized protein C11orf91 homolog
KIAA1549-like ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
KIAA1549-like ortholog, transcript variant X3
KIAA1549-like ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UPF0606 protein KIAA1549L homolog isoform X3
UPF0606 protein KIAA1549L homolog isoform X1
UPF0606 protein KIAA1549L homolog isoform X2
homeodomain interacting protein kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homeodomain interacting protein kinase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
homeodomain interacting protein kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
homeodomain-interacting protein kinase 3 isoform X3
homeodomain-interacting protein kinase 3 isoform X1
homeodomain-interacting protein kinase 3 isoform X2
cleavage stimulation factor, 3' pre-RNA, subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
DEP domain containing 7, transcript variant X1
DEP domain containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DEP domain-containing protein 7 isoform X1
DEP domain-containing protein 7 isoform X2
cat eye syndrome critical region protein 2-like, transcript variant X9
cat eye syndrome critical region protein 2-like, transcript variant X8
cat eye syndrome critical region protein 2-like, transcript variant X7
cat eye syndrome critical region protein 2-like, transcript variant X2
cat eye syndrome critical region protein 2-like, transcript variant X5
cat eye syndrome critical region protein 2-like, transcript variant X6
cat eye syndrome critical region protein 2-like, transcript variant X4
cat eye syndrome critical region protein 2-like, transcript variant X3
cat eye syndrome critical region protein 2-like, transcript variant X1
cat eye syndrome critical region protein 2-like isoform X7
cat eye syndrome critical region protein 2-like isoform X2
cat eye syndrome critical region protein 2-like isoform X5
cat eye syndrome critical region protein 2-like isoform X6
cat eye syndrome critical region protein 2-like isoform X4
cat eye syndrome critical region protein 2-like isoform X3
cat eye syndrome critical region protein 2-like isoform X1
cat eye syndrome critical region protein 2-like isoform X9
cat eye syndrome critical region protein 2-like isoform X8
glutamine and serine rich 1, transcript variant X2
glutamine and serine rich 1, transcript variant X1
glutamine and serine-rich protein 1 isoform X2
glutamine and serine-rich protein 1 isoform X1
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane), transcript variant X2
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane), transcript variant X1
transmembrane gamma-carboxyglutamic acid protein 4
coiled-coil domain containing 73, transcript variant X1
coiled-coil domain containing 73, transcript variant X3
coiled-coil domain-containing protein 73 isoform X1
coiled-coil domain-containing protein 73 isoform X3
coiled-coil domain containing 73, transcript variant X2
coiled-coil domain containing 73, transcript variant X4
coiled-coil domain-containing protein 73 isoform X2
coiled-coil domain-containing protein 73 isoform X4
eukaryotic translation initiation factor 3 subunit M
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
elongator acetyltransferase complex subunit 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
elongator acetyltransferase complex subunit 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
elongator acetyltransferase complex subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
elongator acetyltransferase complex subunit 4, transcript variant X5
elongator acetyltransferase complex subunit 4, transcript variant X1
inner mitochondrial membrane peptidase subunit 1
mitochondrial inner membrane protease subunit 1
DnaJ heat shock protein family (Hsp40) member C24
uncharacterized LOC102685698, transcript variant X2
uncharacterized LOC102685698, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC102685698, transcript variant X4
uncharacterized LOC102685698, transcript variant X3
uncharacterized LOC102685698, transcript variant X5
uncharacterized protein LOC102685698 isoform X1
uncharacterized protein LOC102685698 isoform X3
uncharacterized protein LOC102685698 isoform X2
uncharacterized protein LOC102685698 isoform X4
uncharacterized LOC102685698, transcript variant X6
uncharacterized protein LOC102685698 isoform X5
metallophosphoesterase domain containing 2, transcript variant X1
metallophosphoesterase domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
UEV and lactate/malate dehyrogenase domains
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 134 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 variant 3
cysteine and glycine rich protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cysteine and glycine rich protein 3, transcript variant X1
E2F transcription factor 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
E2F transcription factor 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
E2F transcription factor 8, transcript variant X2
neuron navigator 2, transcript variant X8
neuron navigator 2, transcript variant X2
neuron navigator 2, transcript variant X1
neuron navigator 2, transcript variant X3
neuron navigator 2, transcript variant X4
neuron navigator 2, transcript variant X5
neuron navigator 2, transcript variant X7
neuron navigator 2, transcript variant X6
neuron navigator 2, transcript variant X9
transfer RNA aspartic acid (anticodon GUC); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
neuron navigator 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 6 (neurotransmitter transporter), member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 6 (neurotransmitter transporter), member 5, transcript variant X4
solute carrier family 6 (neurotransmitter transporter), member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 6 (neurotransmitter transporter), member 5, transcript variant X1
sodium- and chloride-dependent glycine transporter 2 isoform X1
sodium- and chloride-dependent glycine transporter 2 isoform X2
neural EGFL like 1, transcript variant X2
neural EGFL like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein kinase C-binding protein NELL1 isoform X1
protein kinase C-binding protein NELL1 isoform X2
glycosyltransferase-like protein LARGE2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycosyltransferase-like protein LARGE2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glycosyltransferase-like protein LARGE2, transcript variant X6
glycosyltransferase-like protein LARGE2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycosyltransferase-like protein LARGE2, transcript variant X4
glycosyltransferase-like protein LARGE2, transcript variant X8
glycosyltransferase-like protein LARGE2, transcript variant X5
glycosyltransferase-like protein LARGE2, transcript variant X7
glycosyltransferase-like protein LARGE2 isoform X1
glycosyltransferase-like protein LARGE2 isoform X2
7-dehydrocholesterol reductase, transcript variant X2
7-dehydrocholesterol reductase, transcript variant X1
7-dehydrocholesterol reductase isoform X1
7-dehydrocholesterol reductase isoform X2
glutamine-dependent NAD(+) synthetase isoform X1
glutamine-dependent NAD(+) synthetase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
anoctamin 1, calcium activated chloride channel, transcript variant X6
anoctamin 1, calcium activated chloride channel, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
anoctamin 1, calcium activated chloride channel, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
anoctamin 1, calcium activated chloride channel, transcript variant X3
anoctamin 1, calcium activated chloride channel, transcript variant X2
anoctamin 1, calcium activated chloride channel, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
anoctamin 1, calcium activated chloride channel, transcript variant X7
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X1
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X3
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X6
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X9
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X5
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X10
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X19
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X2
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X16
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X7
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X18
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X13
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X11
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X15
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3 and multiple ankyrin repeat domains 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
SH3 and multiple ankyrin repeat domains protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 378 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
golgin subfamily B member 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
golgin subfamily B member 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
golgin subfamily B member 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
golgin subfamily B member 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
golgin subfamily B member 1-like, transcript variant X1
golgin subfamily B member 1-like isoform X5
golgin subfamily B member 1-like isoform X3
golgin subfamily B member 1-like isoform X2
golgin subfamily B member 1-like isoform X4
golgin subfamily B member 1-like isoform X1
guanylyl cyclase-activating protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1, transcript variant X3
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1, transcript variant X2
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC107075822, transcript variant X2
uncharacterized LOC107075822, transcript variant X1
para-nitrobenzyl esterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
para-nitrobenzyl esterase-like, transcript variant X3
para-nitrobenzyl esterase-like, transcript variant X2
ADP ribosylation factor GTPase activating protein 2, transcript variant X1
ADP ribosylation factor GTPase activating protein 2, transcript variant X2
ADP-ribosylation factor GTPase-activating protein 2 isoform X2
ADP-ribosylation factor GTPase-activating protein 2 isoform X1
protein kinase C and casein kinase substrate in neurons 3, transcript variant X3
protein kinase C and casein kinase substrate in neurons 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein kinase C and casein kinase substrate in neurons 3, transcript variant X2
protein kinase C and casein kinase substrate in neurons protein 3 isoform X2
protein kinase C and casein kinase substrate in neurons protein 3 isoform X1
protein kinase C and casein kinase substrate in neurons 3, transcript variant X4
protein kinase C and casein kinase substrate in neurons protein 3 isoform X3
damage-specific DNA binding protein 2, transcript variant X1
damage-specific DNA binding protein 2, transcript variant X2
damage-specific DNA binding protein 2, transcript variant X4
damage-specific DNA binding protein 2, transcript variant X5
damage-specific DNA binding protein 2, transcript variant X3
acid phosphatase 2, lysosomal, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
acid phosphatase 2, lysosomal, transcript variant X2
autophagy/beclin-1 regulator 1, transcript variant X3
autophagy/beclin-1 regulator 1, transcript variant X2
autophagy/beclin-1 regulator 1, transcript variant X1
autophagy/beclin-1 regulator 1, transcript variant X4
autophagy/beclin-1 regulator 1, transcript variant X5
activating molecule in BECN1-regulated autophagy protein 1 isoform X1
activating molecule in BECN1-regulated autophagy protein 1 isoform X2
cholinergic receptor, muscarinic 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
muscarinic acetylcholine receptor M4 isoform X1
cholinergic receptor, muscarinic 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
muscarinic acetylcholine receptor M4 isoform X2
midkine (neurite growth-promoting factor 2), transcript variant X2
midkine (neurite growth-promoting factor 2), transcript variant X1
diacylglycerol kinase, zeta, transcript variant X6
diacylglycerol kinase, zeta, transcript variant X3
diacylglycerol kinase, zeta, transcript variant X7
diacylglycerol kinase, zeta, transcript variant X4
diacylglycerol kinase, zeta, transcript variant X2
diacylglycerol kinase, zeta, transcript variant X8
diacylglycerol kinase, zeta, transcript variant X5
diacylglycerol kinase, zeta, transcript variant X1
diacylglycerol kinase, zeta, transcript variant X10
diacylglycerol kinase, zeta, transcript variant X14
diacylglycerol kinase, zeta, transcript variant X13
diacylglycerol kinase, zeta, transcript variant X11
diacylglycerol kinase, zeta, transcript variant X12
diacylglycerol kinase, zeta, transcript variant X15
diacylglycerol kinase, zeta, transcript variant X9
cAMP responsive element binding protein 3-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cyclic AMP-responsive element-binding protein 3-like protein 1
PHD finger protein 21A, transcript variant X3
PHD finger protein 21A, transcript variant X5
PHD finger protein 21A, transcript variant X1
PHD finger protein 21A, transcript variant X4
PHD finger protein 21A, transcript variant X2
ras-related and estrogen-regulated growth inhibitor-like, transcript variant X3
ras-related and estrogen-regulated growth inhibitor-like
harbinger transposase derived 1, transcript variant X2
harbinger transposase derived 1, transcript variant X1
autophagy related 13, transcript variant X1
autophagy related 13, transcript variant X2
autophagy related 13, transcript variant X3
autophagy related 13, transcript variant X4
SPRY domain-containing SOCS box protein 3-like, transcript variant X2
SPRY domain-containing SOCS box protein 3-like, transcript variant X1
SPRY domain-containing SOCS box protein 3-like, transcript variant X4
SPRY domain-containing SOCS box protein 3-like, transcript variant X5
SPRY domain-containing SOCS box protein 3-like, transcript variant X3
SPRY domain-containing SOCS box protein 3-like isoform X1
SPRY domain-containing SOCS box protein 3-like isoform X2
SPRY domain-containing SOCS box protein 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
PR domain containing 11, transcript variant X4
PR domain-containing protein 11 isoform X4
PR domain containing 11, transcript variant X1
PR domain containing 11, transcript variant X10
PR domain containing 11, transcript variant X2
PR domain-containing protein 11 isoform X1
PR domain-containing protein 11 isoform X6
PR domain-containing protein 11 isoform X2
PR domain containing 11, transcript variant X6
PR domain containing 11, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PR domain containing 11, transcript variant X5
PR domain containing 11, transcript variant X3
PR domain-containing protein 11 isoform X3
PR domain containing 11, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PR domain containing 11, transcript variant X8
PR domain-containing protein 11 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
receptor associated protein of the synapse
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
43 kDa receptor-associated protein of the synapse
CUGBP, Elav-like family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
CUGBP, Elav-like family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
CUGBP Elav-like family member 1 isoform X2
CUGBP Elav-like family member 1 isoform X1
protein tyrosine phosphatase, mitochondrial 1
phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1
kelch repeat and BTB (POZ) domain containing 4, transcript variant X2
kelch repeat and BTB (POZ) domain containing 4, transcript variant X1
kelch repeat and BTB domain-containing protein 4 isoform X1
kelch repeat and BTB domain-containing protein 4 isoform X2
NADH:ubiquinone oxidoreductase core subunit S3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial
C1q and tumor necrosis factor related protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 4
low choriolytic enzyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
low choriolytic enzyme-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nuclear pore complex protein Nup160
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial carrier 2, transcript variant X1
mitochondrial carrier 2, transcript variant X2
mitochondrial carrier homolog 2 isoform X1
mitochondrial carrier homolog 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 72 ESTs, 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 39 (zinc transporter), member 13
Spi-1 proto-oncogene, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Spi-1 proto-oncogene, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Spi-1 proto-oncogene, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
myosin binding protein C, cardiac, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
myosin binding protein C, cardiac, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
myosin binding protein C, cardiac, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
myosin binding protein C, cardiac, transcript variant X3
myosin binding protein C, cardiac, transcript variant X6
myosin binding protein C, cardiac, transcript variant X4
myosin-binding protein C, cardiac-type isoform X1
myosin-binding protein C, cardiac-type isoform X5
myosin-binding protein C, cardiac-type isoform X2
myosin-binding protein C, cardiac-type isoform X3
myosin-binding protein C, cardiac-type isoform X6
myosin-binding protein C, cardiac-type isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
MAP kinase-activating death domain protein
nuclear receptor subfamily 1 group H member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ADP ribosylation factor like GTPase 14 effector protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ADP ribosylation factor like GTPase 14 effector protein, transcript variant X1
ADP ribosylation factor like GTPase 14 effector protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ADP ribosylation factor like GTPase 14 effector protein, transcript variant X6
ADP ribosylation factor like GTPase 14 effector protein, transcript variant X2
ADP ribosylation factor like GTPase 14 effector protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
follicle stimulating hormone, beta polypeptide
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
potassium channel, voltage gated shaker related subfamily A, member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily A member 4
probable methyltransferase-like protein 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
brain-derived neurotrophic factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
brain-derived neurotrophic factor isoform X2
brain-derived neurotrophic factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
brain-derived neurotrophic factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
brain-derived neurotrophic factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
brain-derived neurotrophic factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
brain-derived neurotrophic factor, transcript variant X7
brain-derived neurotrophic factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
brain-derived neurotrophic factor isoform X1
brain-derived neurotrophic factor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
brain-derived neurotrophic factor isoform X3
leucine-rich repeat containing G protein-coupled receptor 4
leucine-rich repeat-containing G-protein coupled receptor 4
coiled-coil domain containing 34, transcript variant X3
coiled-coil domain containing 34, transcript variant X1
coiled-coil domain containing 34, transcript variant X2
coiled-coil domain-containing protein 34
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
fin bud initiation factor homolog (zebrafish)
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sodium-coupled monocarboxylate transporter 2
leucine zipper protein 2, transcript variant X1
leucine zipper protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 17 (vesicular glutamate transporter), member 6
transmembrane 7 superfamily member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
tumor suppressing subtransferable candidate 4, transcript variant X5
tumor suppressing subtransferable candidate 4, transcript variant X6
tumor suppressing subtransferable candidate 4, transcript variant X2
tumor suppressing subtransferable candidate 4, transcript variant X3
tumor suppressing subtransferable candidate 4, transcript variant X4
tumor suppressing subtransferable candidate 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
potassium channel, voltage gated Shaw related subfamily C, member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 1
secretion regulating guanine nucleotide exchange factor, transcript variant X2
secretion regulating guanine nucleotide exchange factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
secretion-regulating guanine nucleotide exchange factor isoform X2
secretion-regulating guanine nucleotide exchange factor isoform X1
secretion regulating guanine nucleotide exchange factor, transcript variant X3
secretion-regulating guanine nucleotide exchange factor isoform X3
tryptophan hydroxylase 1, transcript variant X3
tryptophan hydroxylase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tryptophan hydroxylase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tryptophan hydroxylase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tryptophan hydroxylase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
general transcription factor IIH subunit 1-like
uncharacterized LOC107075824, transcript variant X1
uncharacterized LOC107075824, transcript variant X2
uncharacterized protein LOC107075824 isoform X1
uncharacterized protein LOC107075824 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide exchange factor for Rab-3A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns